GCG and metabolic dysfunction-associated steatotic liver disease: KEGG pathway analysis for these genes identified several key signaling pathways, including the insulin signaling pathway, Parkinson's disease, non-alcoholic fatty liver disease (NAFLD), glucagon signaling pathway, and Alzheimer's disease (Figure 3G).